COVID-19: Updates for
Last Updated: April 1, 2020
A MESSAGE FROM ZOETIS CEO KRISTIN PECK
As the novel coronavirus (COVID-19) situation continues to evolve and business impacts are becoming more far reaching across every sector, I wanted to share what we are doing at Zoetis to ensure the continuity in our support of you and the animals in your care. Read more
CUSTOMER SUPPLY AND SERVICE
At this time, there is no direct impact to Zoetis supply, and we continue to monitor closely with distributors.
- If the situation evolves, we have a robust 4-6 months inventory on key products.
- Border controls are evolving along with the situation, region by region. Zoetis has a well-established process to assess and act quickly on these developments and restore operations to normal levels and mitigate further impact to the business.
- Zoetis is monitoring all cargo movements and transportation lanes to ensure successful movement of goods throughout our network.
At this time, all of our manufacturing sites around the world remain open. With the health and safety of our colleagues as our top priority, we are taking great care to ensure continuity at all our manufacturing sites.
- If we need to close a site, Zoetis will leverage its global network and work proactively to ensure manufacturing capabilities meet customer needs.
- We are complying with all local government recommendations for social distancing with flexible work arrangements.
Across our global network, formal plans are underway within our Global Manufacturing & Supply team to bolster our inventory and availability through:
- Increased inventory positions for all aspects of our supply chain: Finished Goods, Active Ingredients and supporting components.
- Deployment of inventory from regional hubs to market-specific warehouses.
Our field sales and technical representatives are available remotely.
- If you require an in-person visit from one of our representatives, please be assured they are following the health and hygiene guidance from the World Health Organization and Centers for Disease Control and Prevention.
- If you work with a Zoetis representative, please reach out to him or her as your first point of contact. Otherwise, please contact us here.
ANIMALS AND COVID-19
According to the World Health Organization, U.S. Centers for Disease Control & Protection and the American Veterinary Medical Association, there is no evidence at this point that companion animals or pets such as cats and dogs can spread the virus that causes COVID-19 to other animals or people.
If a person becomes ill with COVID-19, CDC recommends limited contact with animals and that, if possible, another member of the household takes care of walking, feeding, and playing with pets. If an ill person must care for pets or has a service animal, it is recommended that they wash their hands before and after interacting with pets.
Veterinarians and pet owners may also refer to updates from the World Small Animal Veterinary Association.
According to the Friedrich Loeffler Institute (FLI), the National Institute for Animal Health in Germany, there is currently no evidence that farm animals can contract the SARS-CoV-2 coronavirus (COVID-19) or that livestock can transmit and spread it.
Coronaviruses are generally thought to be spread from person-to-person through respiratory droplets. Currently there is no evidence to support transmission of COVID-19 associated with food. Before preparing or eating food it is important to always wash your hands with soap and water for 20 seconds for general food safety. Throughout the day wash your hands after blowing your nose, coughing or sneezing, or going to the bathroom. (CDC)
What Zoetis is Doing
Through the Zoetis Center for Transboundary and Emerging Diseases, our infectious disease scientists are evaluating technical reports in this rapidly evolving situation to understand if the novel coronavirus is a specific risk to livestock and pets. In response to outbreaks of infectious diseases, the Center mobilizes resources from across our company and works closely with leaders from government, health organizations and the veterinary and livestock agricultural communities to identify disease threats to animals. The Center harnesses our capabilities in vaccine development, alliances with centers of excellence, regulatory affairs and flexible manufacturing capacity.
WHAT WE ARE DOING FOR ZOETIS COLLEAGUES
Since the outbreak began in early January, we have maintained a coordinated response across our global sites to prioritize the safety of our colleagues, the service of our customers, and the quality of our products. Caring for our colleagues is our top priority because we know they make all the difference to customers and we depend on them to deliver our medicines and products. We are following the health guidance of the World Health Organization and the Centers for Disease Control and Prevention at our sites and providing that guidance to our colleagues. We are being flexible with our work and implementing remote and staggered schedules where appropriate, as well as offering colleagues the flexibility to care for their health and families.